Article
Clinical identification of familial chylomicronemia syndrome and novel therapeutic options.
Expert review of cardiovascular therapy - 1 Jan 2026
Hang Shyann, Hegele Robert A
Abstract excerpt
INTRODUCTION: Hypertriglyceridemia (HTG) is a heterogeneous metabolic disorder driven by both genetic susceptibility and secondary factors. Most patients with severe HTG (triglyceride [TG] >10 mmol/L [>885 mg/dL]) have multifactorial chylomicronemia syndrome (MCS) while only a few have familial chylomicronemia syndrome (FCS), a rare autosomal recessive condition. AREAS COVERED: We summarize the pathophysiology of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
